Milestone Pharmaceuticals Inc. — Company profile
Healthcare · Biotechnology · Canada
Last price 0.73 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 102.86M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines in the United States and Canada. It offers CARDAMYST (etripamil) nasal spray, a prescription medication for the conversion of acute symptomatic episodes of paroxysmal supraventricular tachycardia (PSVT) to sinus rhythm in adults. The company is also developing etripamil for the indication of atrial fibrillation with rapid ventricular rate (AFib-RVR). It has a license and collaboration agreement with Corxel Pharmaceuticals to develop and commercialize etripamil. Milestone Pharmaceuticals Inc.was incorporated in 2003 and is headquartered in Montreal, Canada.
Details
| Name | Milestone Pharmaceuticals Inc. |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 38 |
| Founded | 2003 |
| Ceo | Joseph Oliveto |
| Country | Canada |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Isin | CA59935V1076 |
| Cusip | 59935V107 |
| Cik | 1408443 |
| Sic | 2834 |
Key executives
| Name | Title |
|---|---|
| Joseph G. Oliveto M.B.A. | Chief Executive Officer, President and Executive Director |
| Amit Hasija | Chief Financial Officer and Executive Vice President of Corporate Development |
| Dr. David B. Bharucha FACC, M.D., Ph.D. | Chief Medical Officer |
| Dr. Philippe Douville M.B.A., Ph.D. | Founder, Strategic Advisor and Member of Scientific Advisory Board |
| Jeffrey Nelson | Chief Operating Officer |
| David Sandoval | General Counsel and Chief Compliance Officer |
| Roshan Girglani | Vice President of Marketing |
| Jeff Moore | Vice President of Sales |
| Dr. Philip T. Sager FACC, FAHA, FHRS, M.D. | Chief Medical Advisor and Member of the Scientific Advisory Board |
| Dr. Guy Rousseau | SVice President of Regulatory Affairs and Quality Management |
Contact
| Address | 1111 Dr. Frederik-Philips Boulevard, Suite 420, Montreal, QC H4M 2X6, Canada |
| Phone | 514 336 0444 |
| Website | https://www.milestonepharma.com |